ATE463259T1 - Nasenschleimhaut haftende matrix - Google Patents
Nasenschleimhaut haftende matrixInfo
- Publication number
- ATE463259T1 ATE463259T1 AT00991043T AT00991043T ATE463259T1 AT E463259 T1 ATE463259 T1 AT E463259T1 AT 00991043 T AT00991043 T AT 00991043T AT 00991043 T AT00991043 T AT 00991043T AT E463259 T1 ATE463259 T1 AT E463259T1
- Authority
- AT
- Austria
- Prior art keywords
- brain
- mucous membrane
- nasal mucous
- matrix adhesive
- drug
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Psychiatry (AREA)
- Otolaryngology (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Anesthesiology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP24016299 | 1999-08-26 | ||
PCT/JP2000/005739 WO2001015735A1 (fr) | 1999-08-26 | 2000-08-25 | Matrice adherant a la muqueuse nasale |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE463259T1 true ATE463259T1 (de) | 2010-04-15 |
Family
ID=17055427
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT00991043T ATE463259T1 (de) | 1999-08-26 | 2000-08-25 | Nasenschleimhaut haftende matrix |
Country Status (7)
Country | Link |
---|---|
US (1) | US6663883B1 (de) |
EP (1) | EP1206943B1 (de) |
AT (1) | ATE463259T1 (de) |
AU (1) | AU6730400A (de) |
CA (1) | CA2381860C (de) |
DE (1) | DE60044134D1 (de) |
WO (1) | WO2001015735A1 (de) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9707934D0 (en) * | 1997-04-18 | 1997-06-04 | Danbiosyst Uk | Improved delivery of drugs to mucosal surfaces |
AU2001281746C1 (en) * | 2000-07-31 | 2010-09-09 | ISTITUTO GENTILI S.r.l. | Fentanyl composition for nasal administration |
US7618937B2 (en) | 2001-07-20 | 2009-11-17 | Northwestern University | Peptidomimetic polymers for antifouling surfaces |
US8815793B2 (en) | 2001-07-20 | 2014-08-26 | Northwestern University | Polymeric compositions and related methods of use |
US7858679B2 (en) | 2001-07-20 | 2010-12-28 | Northwestern University | Polymeric compositions and related methods of use |
ATE503845T1 (de) | 2001-12-10 | 2011-04-15 | Novartis Pharma Gmbh | Verfahren zur behandlung von psychosen und schizophrenie auf der basis eines polymorphismus im cntf gen |
US7666876B2 (en) * | 2002-03-19 | 2010-02-23 | Vernalis (R&D) Limited | Buprenorphine formulations for intranasal delivery |
US8911831B2 (en) | 2002-07-19 | 2014-12-16 | Northwestern University | Surface independent, surface-modifying, multifunctional coatings and applications thereof |
GB0300531D0 (en) | 2003-01-10 | 2003-02-12 | West Pharm Serv Drug Res Ltd | Pharmaceutical compositions |
US20070068517A1 (en) * | 2005-09-29 | 2007-03-29 | Crohn Steven S | Composition for use with artificial airway devices |
US20080319083A1 (en) * | 2006-01-27 | 2008-12-25 | Asahi Kasei Pharma Corporation | Medicine for transnasal administration |
US7732539B2 (en) | 2006-02-16 | 2010-06-08 | National Science Foundation | Modified acrylic block copolymers for hydrogels and pressure sensitive wet adhesives |
WO2007109141A2 (en) * | 2006-03-16 | 2007-09-27 | Intranasal Therapeutics, Inc. | Pharmaceutical compositions for intranasal administration comprising a melatonin receptor agonist, uses thereof |
US8563117B2 (en) | 2006-08-04 | 2013-10-22 | Phillip B. Messersmith | Biomimetic modular adhesive complex: materials, methods and applications therefore |
WO2008019352A1 (en) | 2006-08-04 | 2008-02-14 | Nerites Corporation | Biomimetic compounds and synthetic methods therefor |
EP1891946A1 (de) * | 2006-08-14 | 2008-02-27 | Santhera Pharmaceuticals (Schweiz) AG | Transmukosale Verabreichung von 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinon |
US8673286B2 (en) | 2007-04-09 | 2014-03-18 | Northwestern University | DOPA-functionalized, branched, poly(aklylene oxide) adhesives |
US8383092B2 (en) | 2007-02-16 | 2013-02-26 | Knc Ner Acquisition Sub, Inc. | Bioadhesive constructs |
US8785491B2 (en) * | 2008-06-19 | 2014-07-22 | Takeda Pharmaceuticals U.S.A., Inc. | Pharmaceutical compositions and methods for treating age-related macular degeneration with melatonin analogues |
CA2817215C (en) | 2010-11-09 | 2017-05-09 | Knc Ner Acquisition Sub, Inc. | Adhesive compounds for use in hernia repair |
KR20140014134A (ko) * | 2011-01-17 | 2014-02-05 | 다케다 야쿠힌 고교 가부시키가이샤 | 구강내 분산정 |
JP6061924B2 (ja) | 2011-10-14 | 2017-01-18 | 武田薬品工業株式会社 | 口腔内分散性製剤 |
JP7487443B2 (ja) * | 2019-09-30 | 2024-05-21 | ハウスウェルネスフーズ株式会社 | 粘膜上皮適用組成物 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6185332A (ja) * | 1984-10-04 | 1986-04-30 | Kao Corp | 経粘膜吸収促進剤及びこれを含有する経粘膜投与用製剤 |
US5071875A (en) | 1989-09-25 | 1991-12-10 | Northwestern University | Substituted 2-amidotetralins as melatonin agonists and antagonists |
FR2658818B1 (fr) | 1990-02-27 | 1993-12-31 | Adir Cie | Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
TW209174B (de) | 1991-04-19 | 1993-07-11 | Takeda Pharm Industry Co Ltd | |
IT1250421B (it) | 1991-05-30 | 1995-04-07 | Recordati Chem Pharm | Composizione farmaceutica a rilascio controllato con proprieta' bio-adesive. |
IT1254995B (it) | 1992-06-24 | 1995-10-11 | Farmaco contenente melatonina e/o agonisti, con somministrazione particolarmente efficace nelle patologie che interferiscono con i ritmi circandiani | |
US5744155A (en) | 1993-08-13 | 1998-04-28 | Friedman; Doron | Bioadhesive emulsion preparations for enhanced drug delivery |
ES2145102T3 (es) | 1993-09-09 | 2000-07-01 | Takeda Chemical Industries Ltd | Formulacion que comprende una sustancia antibacteriana y una sustancia antiulcerosa. |
FR2712807B1 (fr) | 1993-11-24 | 1996-02-23 | Vetoquinol Sa | Composition solide mucoadhésive, thérapeutique ou hygiénique, pour administration par application sur la muqueuse buccale ou nasale . |
US5688520A (en) * | 1995-03-29 | 1997-11-18 | Minnesota Mining And Manufacturing Company | Transmucosal delivery of melatonin for prevention of migraine |
WO1998042323A1 (en) | 1997-03-25 | 1998-10-01 | Takeda Chemical Industries, Ltd. | Stabilized urease inhibitor |
WO1998042311A1 (en) | 1997-03-25 | 1998-10-01 | Takeda Chemical Industries, Ltd. | Gastrointestinal mucosa-adherent pharmaceutical composition |
-
2000
- 2000-08-25 AT AT00991043T patent/ATE463259T1/de not_active IP Right Cessation
- 2000-08-25 EP EP00991043A patent/EP1206943B1/de not_active Expired - Lifetime
- 2000-08-25 AU AU67304/00A patent/AU6730400A/en not_active Abandoned
- 2000-08-25 DE DE60044134T patent/DE60044134D1/de not_active Expired - Lifetime
- 2000-08-25 WO PCT/JP2000/005739 patent/WO2001015735A1/ja active Application Filing
- 2000-08-25 CA CA002381860A patent/CA2381860C/en not_active Expired - Fee Related
- 2000-08-25 US US10/069,072 patent/US6663883B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP1206943A4 (de) | 2004-06-23 |
CA2381860A1 (en) | 2001-03-08 |
EP1206943A1 (de) | 2002-05-22 |
DE60044134D1 (de) | 2010-05-20 |
US6663883B1 (en) | 2003-12-16 |
EP1206943B1 (de) | 2010-04-07 |
AU6730400A (en) | 2001-03-26 |
WO2001015735A1 (fr) | 2001-03-08 |
CA2381860C (en) | 2009-11-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE463259T1 (de) | Nasenschleimhaut haftende matrix | |
ATE315420T1 (de) | Elektrodenleitung zur stimulation von wirbelsaülen | |
AU9287401A (en) | Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders | |
BR0316969A (pt) | Tratamento de mal de huntington com epa | |
ATE472325T1 (de) | Intrakorporale medikamente zur photodynamischen behandlung von erkrankungen | |
EP1181948A3 (de) | Katheterleitung zur Implantation in dem Intrathekalen Raum | |
ATE517615T1 (de) | Schmerzstillendes und entzündungshemmendes pflaster zur lokalen anwendung | |
CO4770978A1 (es) | Empleo de epinastina para el tratamiento de dolores | |
FI980822A0 (fi) | Farmaseuttinen koostumus vaikuttavan aineen iho- tai limakalvopintaan tai iho- tai limakalvopinnan läpi | |
DE60029566D1 (de) | In-vitro herstellung von transplantierbarem knorpelgewebe | |
AR024944A1 (es) | Amidas de acidos carboxilicos, medicamentos que contienen estos compuestos, su utilizacion y su preparacion | |
WO2003039620A3 (en) | Integrated transdermal drug delivery system | |
NO20013958L (no) | Legemiddel for behandling av höyt blodtrykk | |
WO2004041127A3 (en) | Medical devices including a magnetically activatable body or portion | |
PL372666A1 (en) | Derivatives of alpha-phenylthiocarboxylic and alpha-phenyloxy-carboxylic acids useful for the treatment of diseases responding to ppar alpha activation | |
NO20025394D0 (no) | Formuleringer inneholdende et glukokorticoid legemiddel for behandling av bronkopulmonire sykdommer | |
DE69608122D1 (de) | Mikroverkapselte dna zur impfung und gentherapie | |
AU7222598A (en) | Treatment of depression and anxiety using docosahexaenoic acid or natural antioxidants | |
AU2001240674A1 (en) | Dihydropyrimidine-5-carboxylic acid esters and use thereof as medicaments against viral diseases | |
AU2003271049A1 (en) | Use of amide or ester of sugar and of fatty acid, for treating and/or preventing dry skin | |
PT900563E (pt) | Producao de formulacoes farmaceuticas para o tratamento de edema e doencas venosas | |
AU2003282065A1 (en) | Nasal stick for the applocation of medicaments and skin care substances | |
DE60107888D1 (de) | Beta-Interferon zur Behandlung von Immunerkrankungen | |
DE60043648D1 (de) | Medikamente zur behandlung von periodontalen erkrankungen | |
DE69740081D1 (de) | Kugelanordnungssubstrat zur herstellung von höckern, kugelanordnungskopf, kugelanordnungsvorrichtung und kugelanordnungsverfahren |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |